Tag:
Daniel Zurr
Latest Headlines
Latest Headlines
Quark Pharma snares $27M for RNAi work
Quark Pharmaceuticals has garnered $27 million in a new round of venture financing. The RNAi developer attracted the support of SBI Asset Management and SBI Investment, subsidiaries of the
